TrialCancer immunology, immunotherapy : CII2015

Randomized controlled phase III trial of adjuvant chemo-immunotherapy with activated killer T cells and dendritic cells in patients with resected primary lung cancer.

Hideki Kimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.